Skip to content
naulon
Not checkedNot checked for notices yet.

Commentary: Lung failure has been waiting for thisCentral Message

Pedro Reck dos Santos, MD, MSc, Jonathan D'Cunha, MD, PhD

JTCVS Open · 2021

doi:10.1016/j.xjon.2021.11.001 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Implantable portable devices that can offer alternatives to the current mechanical circulatory support (MCS) platforms are essential because they can theoretically allow the patient to transition from an intensive care unit to the ward or even the outpatient setting. The field of heart failure was transformed when this possibility was realized in the 1990s with the development of the left ventricular assist device (LVAD). Griffith and colleagues1 discuss an exciting strategy that can, as pointed out by the authors, “permit [extracorporeal membrane oxygenation] ECMO systems to leave at the bedside, encourage exercise, and be suitable for use out-of-hospital.”

Abstract licence: CC BY-NC-ND

References4

    4 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.